Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
Associated filings
- 30 May 23 EFFECT Notice of effectiveness
-
22 May 23 POS AM Prospectus update (post-effective amendment)
- 12 May 23 POS AM Prospectus update (post-effective amendment)
- 5 Jan 23 EFFECT Notice of effectiveness
- 4 Jan 23 S-1/A IPO registration (amended)
- 20 Dec 22 S-1/A IPO registration (amended)
- 21 Nov 22 S-1/A IPO registration (amended)
- 21 Sep 22 S-1 IPO registration
MNKA similar filings
Filing view
External links
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the use, in this post-effective amendment no. 2 to Form S-1, of our report dated March 30, 2023, relating to the financial statements of Artemis Therapeutics Inc. We also consent to the reference to us under the heading "Experts" in such Registration Statement.
/s/ Brightman Almagor Zohar & Co.
Brightman Almagor Zohar & Co.
Certified Public Accountants
A Firm in the Deloitte Global Network
Tel Aviv, Israel
May 22, 2023